Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01828307 · ClinicalTrials.gov registry record · NA

Exercise: Addressing Stress in Relapse Prevention for Substance Use Disorders

A NA study, sponsored by St. Louis University.

Completed
Registry status
NA
Development phase
147
Enrollment target

NCT01828307 is a NA study that has completed, run by St. Louis University. The registered enrollment target is 147 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01828307, a NA study, has completed, sponsored by St. Louis University.

COMPLETED
Registry status
NA
Development phase
147 participants
Enrollment target

Study Summary

Relapse contributes significantly to the chronicity of substance use disorders, one of the most costly medical/mental health problems facing our nation. The incorporation of exercise into relapse prevention efforts will address stress, a critical factor in relapse, provide other health benefits, and improve overall quality of life. Combined, these changes will reduce the risk of relapse to substance use while also lessening the burden of this psychiatric disorder upon society

Interventions

  • BEHAVIORAL Contingency management
  • BEHAVIORAL Motivational enhancement therapy (MET)
  • BEHAVIORAL Standard Aftercare Treatment

Trial Details

FieldValue
Enrollment Target 147 participants
Start Date 2013-04
Est. Completion 2019-03
Phase NA

Sponsor

St. Louis University

107 total trials

What the Registry Record Tells You About NCT01828307

The ClinicalTrials.gov registry entry for NCT01828307 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 147 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is St. Louis University, which has 107 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 3 interventions - of which Contingency management is the first listed.

NCT01828307 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01828307 about?

NCT01828307 is a clinical study titled "Exercise: Addressing Stress in Relapse Prevention for Substance Use Disorders". Relapse contributes significantly to the chronicity of substance use disorders, one of the most costly medical/mental health problems facing our nation. The incorporation of exercise into relapse prevention efforts will address stress, a critical factor in relapse, provide other health benefits, and...

What is the current status of trial NCT01828307?

This trial is currently completed. It is a NA study. The enrollment target is 147 participants. The study started on 2013-04. Estimated completion is 2019-03.

What interventions are being tested in trial NCT01828307?

The interventions under investigation include: Contingency management (BEHAVIORAL), Motivational enhancement therapy (MET) (BEHAVIORAL), Standard Aftercare Treatment (BEHAVIORAL).

Who is sponsoring clinical trial NCT01828307?

This trial is sponsored by St. Louis University, which has 107 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.